- Home
- AACG vs GNTA Comparison
AACG vs GNTA Comparison
Compare AACG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AACG | GNTA |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | China | Italy |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.9M | 41.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AACG | GNTA |
|---|---|---|
| Price | $0.86 | $1.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.7K | ★ 118.4K |
| Earning Date | 11-12-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,316,403.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.62 | N/A |
| 52 Week Low | $0.70 | $1.28 |
| 52 Week High | $2.58 | $10.00 |
Technical Indicators
Market Signals| Indicator | AACG | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.39 | 35.61 |
| Support Level | $0.84 | $1.28 |
| Resistance Level | $1.00 | $1.77 |
| Average True Range (ATR) | 0.07 | 0.18 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 7.01 | 22.78 |
Price Performance
Historical ComparisonAbout AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.